JVJustin Vinh

Justin Vinh

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Justin Vinh has a total of 14 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Characteristics, Diagnosis, and Treatment of Aphasia in Patients With Brain Tumors

    by Alexander Finnemore, Maria T. Paulino, Paul J. Miller, Amy J. Maguire, Justin Vinh, Rupal Patel, David Caplan, Kathrin Milbury, Carrie G. Wade, James A. Tulsky, et al.

    Background and ObjectivesTumor-related aphasia (TRA) affects approximately 24% of patients with brain tumors and significantly influences quality of life; yet, few studies have examined TRA across ...

  • When Is the Right Time? A Qualitative Study of Timing of Specialty Palliative Care in Patients With Brain Tumors

    by John Y. Rhee, Paul Miller, Zachary Tentor, Justin Vinh, James A. Tulsky, Amanda Reich, Alexi A. Wright, Charlotta Lindvall

    PURPOSE: To understand from patients, care partners (P/CPs), and physicians the ideal timing of specialty palliative care (SPC) involvement. METHODS: Using a framework of phenomenology and care ethics, we analyzed interviews through a thematic analysis approach. Two investigators independently coded transcripts of recorded interviews. P/CPs were recruited from a single hospital clinic from multiple different oncologists. Physicians were recruited via purposeful snowball sampling based on their knowledge and expertise. RESULTS: Thirty-one participants were recruited: 14 (45%) P/CPs and 17 (55%) clinicians. The mean age of P/CP was 49 years, whereas clinicians' mean age was 44 years. Half of P/CPs were female, and a similar portion of clinicians (53%) were female. More than half of patients had gliomas (57%), and all clinicians were physicians who had practiced neuro-oncology for a mean of 12 years. We identified four themes: (1) Participants felt patients would have benefited from earlier SPC, but there were slight differences in timing based on brain tumor type and grade; (2) neuro-oncology patients have unique supportive care needs compared to other cancers; (3) specialty knowledge of neuro-oncology is important to P/CP for advance care planning, prognostication, and anticipatory guidance; and (4) the broadly intensive role played by care partners in neuro-oncology means they have equally heavy supportive needs. CONCLUSION: This is one of the first studies to explore timing of SPC for patients with CNS tumors. P/CPs and clinicians agreed that early, time-based SPC is beneficial for management of high-grade tumors. Increasing knowledge of neuro-oncology among SPC clinicians working with this population is an area for further study.